RU2714168C2 - Интраназальное введение - Google Patents

Интраназальное введение Download PDF

Info

Publication number
RU2714168C2
RU2714168C2 RU2017114951A RU2017114951A RU2714168C2 RU 2714168 C2 RU2714168 C2 RU 2714168C2 RU 2017114951 A RU2017114951 A RU 2017114951A RU 2017114951 A RU2017114951 A RU 2017114951A RU 2714168 C2 RU2714168 C2 RU 2714168C2
Authority
RU
Russia
Prior art keywords
length
nose tip
tip according
nasal
projection
Prior art date
Application number
RU2017114951A
Other languages
English (en)
Russian (ru)
Other versions
RU2017114951A3 (enExample
RU2017114951A (ru
Inventor
Пер Гисле ДЬЮПЕСЛАНД
Колин Дэвид ШЕЛДРЕЙК
Original Assignee
Оптиноуз Ас
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Оптиноуз Ас filed Critical Оптиноуз Ас
Publication of RU2017114951A publication Critical patent/RU2017114951A/ru
Publication of RU2017114951A3 publication Critical patent/RU2017114951A3/ru
Application granted granted Critical
Publication of RU2714168C2 publication Critical patent/RU2714168C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/08—Inhaling devices inserted into the nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0013—Details of inhalators; Constructional features thereof with inhalation check valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0091—Inhalators mechanically breath-triggered
    • A61M15/0098—Activated by exhalation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M29/00—Dilators with or without means for introducing media, e.g. remedies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/06—Head
    • A61M2210/0618—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Otolaryngology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RU2017114951A 2014-11-19 2015-11-19 Интраназальное введение RU2714168C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462081742P 2014-11-19 2014-11-19
US62/081,742 2014-11-19
PCT/EP2015/077166 WO2016079271A1 (en) 2014-11-19 2015-11-19 Intranasal administration

Publications (3)

Publication Number Publication Date
RU2017114951A RU2017114951A (ru) 2018-12-19
RU2017114951A3 RU2017114951A3 (enExample) 2019-04-16
RU2714168C2 true RU2714168C2 (ru) 2020-02-12

Family

ID=54695714

Family Applications (2)

Application Number Title Priority Date Filing Date
RU2017114951A RU2714168C2 (ru) 2014-11-19 2015-11-19 Интраназальное введение
RU2017114950A RU2017114950A (ru) 2014-11-19 2015-11-19 Интраназальное введение

Family Applications After (1)

Application Number Title Priority Date Filing Date
RU2017114950A RU2017114950A (ru) 2014-11-19 2015-11-19 Интраназальное введение

Country Status (19)

Country Link
US (6) US11052204B2 (enExample)
EP (3) EP3220989B1 (enExample)
JP (2) JP6990583B2 (enExample)
KR (2) KR20170085121A (enExample)
CN (3) CN106999684B (enExample)
AU (2) AU2015348301B2 (enExample)
BR (2) BR112017010561A2 (enExample)
CA (2) CA2966797C (enExample)
DK (2) DK3220989T3 (enExample)
ES (3) ES2949052T3 (enExample)
HK (1) HK1244729A1 (enExample)
IL (2) IL251935A0 (enExample)
MX (2) MX383241B (enExample)
MY (1) MY188242A (enExample)
PL (1) PL3220989T3 (enExample)
RU (2) RU2714168C2 (enExample)
SG (2) SG11201703792XA (enExample)
WO (2) WO2016079267A1 (enExample)
ZA (1) ZA201704149B (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0311570D0 (en) 2003-05-20 2003-06-25 Optinose As Delivery device and method
GB0320171D0 (en) 2003-08-28 2003-10-01 Optinose As Delivery devices
GB0420513D0 (en) 2004-09-15 2004-10-20 Optinose As Powder delivery devices
GB0503738D0 (en) 2005-02-23 2005-03-30 Optinose As Powder delivery devices
GB0604444D0 (en) * 2006-03-06 2006-04-12 Optinose As Nasal devices
GB0605799D0 (en) 2006-03-23 2006-05-03 Optinose As Nasal delivery devices
GB2438834A (en) 2006-06-08 2007-12-12 Optinose As Intranasal protein administration
GB2440316A (en) 2006-07-25 2008-01-30 Optinose As Nasal inhaler with scrubber
GB0623732D0 (en) 2006-11-28 2007-01-10 Optinose As Powder delivery devices
GB0623728D0 (en) 2006-11-28 2007-01-10 Optinose As Delivery devices
GB0623731D0 (en) 2006-11-28 2007-01-10 Optinose As Delivery device
GB2448183A (en) 2007-04-05 2008-10-08 Optinose As Nasal powder delivery device
GB2448193A (en) 2007-04-05 2008-10-08 Optinose As Nasal delivery device
GB0719299D0 (en) 2007-10-03 2007-11-14 Optinose As Nasal delivery devices
US9949923B2 (en) 2011-03-15 2018-04-24 Optinose As Nasal delivery
JP6243360B2 (ja) 2012-02-24 2017-12-06 オプティノーズ アズ 経鼻配送装置
US11554229B2 (en) 2013-03-26 2023-01-17 OptiNose Inc. Nasal administration
USD761951S1 (en) 2013-05-23 2016-07-19 Optinose As Nosepiece unit
ES2949052T3 (es) 2014-11-19 2023-09-25 Optinose Inc Administración intranasal
US10368502B2 (en) 2017-09-25 2019-08-06 Multiple Energy Technologies Llc Bioceramic and carbon-based hydroponic systems, methods and devices
DK3773834T3 (da) 2018-04-12 2025-05-19 Rocket Science Health Corp Intranasal fluidindgivelsesanordning
KR102148613B1 (ko) * 2019-01-28 2020-10-14 닉스 주식회사 이산화탄소를 이용한 수면 유도시스템
CN110188836B (zh) * 2019-06-21 2021-06-11 西安交通大学 一种基于变分自编码器的脑功能网络分类方法
US20220313895A1 (en) * 2019-08-14 2022-10-06 Gsk Consumer Healthcare Sarl Bi-material nozzle for nasal washes
US11241477B2 (en) 2019-08-29 2022-02-08 New York University Oxytocin compositions for treatment of tinnitus
EP4073214A4 (en) 2019-12-09 2023-12-27 AAK AB (publ) Wax compositions for use in candles and methods of preparing wax compositions
US20220161000A1 (en) * 2020-11-24 2022-05-26 Medtronic, Inc. Multi-durometer attachment device for chronic fixation
CN121288169A (zh) * 2021-04-20 2026-01-09 苏州新劢德医疗器械科技有限公司 一种流体分配设备
CN121550561A (zh) * 2021-04-20 2026-02-24 苏州新劢德医疗器械科技有限公司 流体分配设备
CN114306207A (zh) * 2021-12-30 2022-04-12 电子科技大学 一种以棒棒糖为载体的口腔给药方法
US20230285278A1 (en) * 2022-03-06 2023-09-14 Optinose, Inc. Methods for treating chronic rhinosinusitis
WO2025118074A1 (en) * 2023-12-04 2025-06-12 Rocket Science Health Corp. Olfactory delivery of therapeutic peptides
US20250255745A1 (en) * 2024-02-13 2025-08-14 Breathewave Technologies Inc. Personalized-fit nasal dilator

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09135901A (ja) * 1995-11-15 1997-05-27 Unisia Jecs Corp 鼻腔用投薬器
RU2383358C2 (ru) * 2005-10-04 2010-03-10 Омрон Хэлткэа Ко., Лтд. Ингалятор и мундштук ингалятора
US20100282246A1 (en) * 2007-04-05 2010-11-11 Optinose As Nasal delivery
RU112044U1 (ru) * 2011-08-25 2012-01-10 Наиль Минрахманович Нуртдинов Тренажер-ингалятор
US8550073B2 (en) * 2006-03-06 2013-10-08 Optinose As Nasal delivery

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US605436A (en) 1898-06-07 Inhaler
US642748A (en) 1899-02-23 1900-02-06 Arthur Manners Inhaler.
US658436A (en) 1900-05-28 1900-09-25 Hans Hennerich Groth Insufflator.
US746749A (en) 1903-03-18 1903-12-15 George E Seidel Nasal medicator.
US794641A (en) 1905-03-06 1905-07-11 Alfred H Ramey Inhaler.
US902832A (en) 1907-09-20 1908-11-03 Edward F Philbrook Inhaler.
AU693306B2 (en) 1995-01-23 1998-06-25 Direct-Haler A/S An inhaler
US5901703A (en) 1995-02-06 1999-05-11 Unisia Jecs Corporation Medicine administering device for nasal cavities
US5797392C1 (en) 1996-01-22 2001-01-09 Direct Haler As Inhaler
BR9809499A (pt) 1997-05-27 2000-06-20 Direct Haler A S Inalador para medicamentos em pó
GB9719775D0 (en) * 1997-09-18 1997-11-19 Glaxo Group Ltd Device
FR2771296B1 (fr) 1997-11-25 2000-03-10 Sofab Embout nasal avec fermeture d'extremite
NZ514442A (en) 1999-03-03 2003-08-29 Optinose As Nasal delivery device
GB0114272D0 (en) 2001-06-12 2001-08-01 Optinose As Nasal delivery device
GB0121568D0 (en) 2001-09-06 2001-10-24 Optinose As Nasal delivery device
US20070032410A1 (en) 2000-01-11 2007-02-08 Atossa Healthcare, Inc. Compositions and methods for the treatment of psychiatric disorders
US6894026B1 (en) 2000-01-11 2005-05-17 Atossa Healthcare, Inc. Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disorders
GB0015309D0 (en) 2000-06-21 2000-08-16 Djupesland Per G Apparatus
ZA200306564B (en) 2001-02-26 2004-10-15 Optinose As Nasal devices.
GB0207422D0 (en) 2002-03-28 2002-05-08 Optinose As Nasal devices
GB0207817D0 (en) 2002-04-04 2002-05-15 Optinose As Nasal devices
GB0209494D0 (en) 2002-04-25 2002-06-05 Optinose As Nasal devices
GB0215270D0 (en) 2002-07-02 2002-08-14 Optinose As Nasal devices
GB0215904D0 (en) 2002-07-09 2002-08-21 Team Holdings Uk Ltd Drug delivery system and method
GB0300008D0 (en) 2003-01-02 2003-02-05 Optinose As Delivery devices
GB2400565B (en) 2003-04-17 2005-03-02 Bespak Plc Nasal drug delivery
GB0311570D0 (en) 2003-05-20 2003-06-25 Optinose As Delivery device and method
GB0319119D0 (en) * 2003-08-14 2003-09-17 Optinose As Delivery devices
GB0320171D0 (en) 2003-08-28 2003-10-01 Optinose As Delivery devices
GB0405477D0 (en) 2004-03-11 2004-04-21 Glaxo Group Ltd A fluid dispensing device
USD530815S1 (en) 2004-03-19 2006-10-24 Optinose As Nasal delivery device
GB0420513D0 (en) 2004-09-15 2004-10-20 Optinose As Powder delivery devices
GB0503738D0 (en) 2005-02-23 2005-03-30 Optinose As Powder delivery devices
JP5276982B2 (ja) 2005-08-26 2013-08-28 ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ オキシトシンの投与による頭痛の処置のための方法
US10478574B2 (en) 2006-01-19 2019-11-19 Optinose As Nasal administration
WO2007093784A1 (en) 2006-02-14 2007-08-23 Optinose As Delivery device and method
GB0602980D0 (en) 2006-02-14 2006-03-29 Optinose As Delivery device and method
GB0604319D0 (en) 2006-03-03 2006-04-12 Optinose As Nasal delivery
GB0605799D0 (en) 2006-03-23 2006-05-03 Optinose As Nasal delivery devices
GB2437488A (en) 2006-04-25 2007-10-31 Optinose As Pharmaceutical oily formulation for nasal or buccal administration
GB2438834A (en) 2006-06-08 2007-12-12 Optinose As Intranasal protein administration
GB2440316A (en) 2006-07-25 2008-01-30 Optinose As Nasal inhaler with scrubber
JP2008062974A (ja) 2006-09-07 2008-03-21 Mitani Valve Co Ltd 内容物放出用容器ならびに、この内容物放出用容器を備えたポンプ式製品およびエアゾール式製品
GB0623731D0 (en) 2006-11-28 2007-01-10 Optinose As Delivery device
GB0623732D0 (en) 2006-11-28 2007-01-10 Optinose As Powder delivery devices
GB0623728D0 (en) 2006-11-28 2007-01-10 Optinose As Delivery devices
WO2008122018A1 (en) 2007-04-02 2008-10-09 Abbott Respiratory Llc Breath actuated nasal pump
GB2448183A (en) 2007-04-05 2008-10-08 Optinose As Nasal powder delivery device
US8342173B2 (en) 2007-07-19 2013-01-01 Silver Eagle Labs Inc. Nasal dilator with cushion layer and variable spring rate
GB0719299D0 (en) 2007-10-03 2007-11-14 Optinose As Nasal delivery devices
CN101980738A (zh) 2008-02-07 2011-02-23 华盛顿大学 圆周气雾设备
EP2242526A4 (en) 2008-02-15 2014-06-18 Timothy Sean Immel AEROSOL TREATMENT DEVICE WITH HIGH FREQUENCY ADMINISTRATION
WO2010029441A2 (en) 2008-09-15 2010-03-18 Optinose As Nasal delivery
GB201015371D0 (en) 2010-09-14 2010-10-27 Optinose As Nasal delivery
GB201020638D0 (en) * 2010-12-06 2011-01-19 Liconsa Laboratorios Sa Inhalator
US9949923B2 (en) * 2011-03-15 2018-04-24 Optinose As Nasal delivery
JP6243360B2 (ja) 2012-02-24 2017-12-06 オプティノーズ アズ 経鼻配送装置
ES2774159T5 (en) 2012-02-24 2025-09-29 Optinose Inc Nasal delivery devices
PL2817053T3 (pl) 2012-02-24 2019-01-31 Optinose As Urządzenia do podawania donosowego
US11554229B2 (en) 2013-03-26 2023-01-17 OptiNose Inc. Nasal administration
US20160045687A1 (en) 2013-03-26 2016-02-18 Optinose As Nasal administration
USD725769S1 (en) 2013-05-23 2015-03-31 Optinose As Nasal delivery device
USD723156S1 (en) 2013-05-23 2015-02-24 Optinose As Nasal delivery device
USD761951S1 (en) 2013-05-23 2016-07-19 Optinose As Nosepiece unit
ES2949052T3 (es) 2014-11-19 2023-09-25 Optinose Inc Administración intranasal
US20220296825A1 (en) 2018-10-04 2022-09-22 Optinose As Exhalation delivery system for and method of treating sinus disease

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09135901A (ja) * 1995-11-15 1997-05-27 Unisia Jecs Corp 鼻腔用投薬器
RU2383358C2 (ru) * 2005-10-04 2010-03-10 Омрон Хэлткэа Ко., Лтд. Ингалятор и мундштук ингалятора
US8550073B2 (en) * 2006-03-06 2013-10-08 Optinose As Nasal delivery
US20100282246A1 (en) * 2007-04-05 2010-11-11 Optinose As Nasal delivery
RU112044U1 (ru) * 2011-08-25 2012-01-10 Наиль Минрахманович Нуртдинов Тренажер-ингалятор

Also Published As

Publication number Publication date
EP3220989B1 (en) 2020-06-24
PL3220989T3 (pl) 2021-03-22
CN111921046A (zh) 2020-11-13
EP3733235C0 (en) 2023-06-14
IL251936B (en) 2020-07-30
MX2017006268A (es) 2017-08-14
EP3220988A1 (en) 2017-09-27
EP3733235A1 (en) 2020-11-04
AU2015348301B2 (en) 2020-09-03
CA2966797A1 (en) 2016-05-26
KR20170086599A (ko) 2017-07-26
EP3733235B1 (en) 2023-06-14
CN107106792A (zh) 2017-08-29
JP6990583B2 (ja) 2022-01-12
CA2966802C (en) 2022-11-15
KR20170085121A (ko) 2017-07-21
ES2813442T3 (es) 2021-03-23
MY188242A (en) 2021-11-24
CA2966797C (en) 2023-06-27
ES2906984T3 (es) 2022-04-21
BR112017010561A2 (pt) 2017-12-26
RU2017114950A (ru) 2018-12-19
WO2016079271A1 (en) 2016-05-26
BR112017010522B1 (pt) 2022-08-02
DK3220988T3 (da) 2022-02-14
MX383241B (es) 2025-03-13
SG11201703794TA (en) 2017-06-29
JP6937690B2 (ja) 2021-09-22
JP2017538477A (ja) 2017-12-28
AU2015348301A1 (en) 2017-05-25
US11730904B2 (en) 2023-08-22
EP3220989A1 (en) 2017-09-27
US11707586B2 (en) 2023-07-25
US20160310683A1 (en) 2016-10-27
IL251936A0 (en) 2017-06-29
EP3220988B1 (en) 2022-01-12
US20250114543A1 (en) 2025-04-10
ES2949052T3 (es) 2023-09-25
CN106999684A (zh) 2017-08-01
ZA201704149B (en) 2019-12-18
DK3220989T3 (da) 2020-08-24
JP2017538478A (ja) 2017-12-28
RU2017114951A3 (enExample) 2019-04-16
SG11201703792XA (en) 2017-06-29
IL251935A0 (en) 2017-06-29
AU2015348297A1 (en) 2017-05-25
WO2016079267A1 (en) 2016-05-26
US20210275761A1 (en) 2021-09-09
US10940277B2 (en) 2021-03-09
US20230372647A1 (en) 2023-11-23
RU2017114951A (ru) 2018-12-19
CN111921046B (zh) 2022-07-22
HK1244729A1 (zh) 2018-08-17
US20160331916A1 (en) 2016-11-17
US20210322690A1 (en) 2021-10-21
CA2966802A1 (en) 2016-05-26
CN107106792B (zh) 2020-08-18
BR112017010522A2 (pt) 2017-12-26
US11052204B2 (en) 2021-07-06
CN106999684B (zh) 2021-03-09
HK1244728A1 (en) 2018-08-17
MX2017006265A (es) 2017-08-14

Similar Documents

Publication Publication Date Title
US11730904B2 (en) Intranasal administration
Abercrombie et al. Orienting, emotion, and memory: Phasic and tonic variation in heart rate predicts memory for emotional pictures in men
Millard et al. Effects of nicotine compared to placebo gum on sensitivity to pain and mediating effects of peak alpha frequency
Ricchiuti et al. Oxytocin’s social and stress-regulatory effects in children with autism and intellectual disability: a protocol for a randomized placebo-controlled trial
HK40033122A (en) Intranasal administration
HK1244728B (en) Intranasal administration
Almarzooqi et al. Skin Deep: An Overlap of Delusions